Morphine modulates NFκB activation in macrophages

Biochemical and Biophysical Research Communications

Volumn 245, Issue 2, 1998, Pages 392-396

  Roy, Sabita ^a,b   Cain, Kelly J ^a   Chapin, Rebecca B ^a   Charboneau, Richard G ^b   Barke, Roderick A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MORPHINE; NALOXONE; OPIATE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; IMMUNE SYSTEM; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 0032540140     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.8415     Document Type: Article

References (26)

1. Roy S., Loh H. H. Effects of Opioids on the Immune System. Neurochemical Research. 21:1996;1373-1384.
2. Fecho K., Maslonek K. A., Coussons-Read M. E., Dykstra L. A., Lysle D. T. Macrophage-derived nitric oxide is involved in the depressed con A-responsiveness of splenic lymphocytes from rats administered morphinein vivo. J. Immunol. 152:1994;5845-5852.
3. Sharp B. M., Keane W. F., Suh H. J., Gekker G., Tsukayama D., Peterson P. K. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology. 117:1985;793-795.
4. Pacifici R., Di Carlo S., Bacosi A., Zuccaro P. Macrophage Functions in Drugs of Abuse treated mice. Int. J. Immunopharmac. 15:1993;711-716.
5. Szabo, I. Rojavin, M. Bussiere, J. L. Eisenstein, T. K. Adler, M. W. Rojers, T. J. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids, J. Pharmacol. Expt. Therap. 267, 703, 706.
6. Tubaro E., Santiangeli C., Belogi L., Borelli G., Cavallo G., Croce C., Avico U. Methadone vs morphine: comparison of their effect on phagocytic functions. International Journal of Immunopharmacology. 9:1987;79-88.
7. Tomei E. Z., Renaud F. L. Effect of morphine on Fc-mediated phagocytosis by murine macrophages in vitro. J. Neuroimmunol. 74:1997;111-116.
8. Koff W. C., Dunegon M. A. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immunol. 135:1985;350-354.
9. Pacifici R., Minetti M., Zuccaro P., Pietraforte D. Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release. Int. J. Immunopharmacol. 17:1995;771-777.
10. Bian, T. H. Wang, X. F. Li, X. Y. 1995, Effect of morphine on IL-1 and tumor necrosis factor alpha production from mouse peritoneal macrophages in vitro Chung-Kuo Yao Li Hsueh Pao - Acta Pharmacologica Sinica, 16, 449, 451.
11. House R. V., Thomas P. T., Bhargava H. N. In vitro evaluation of fentanyl and meperidine for immunomodulatory. Immunology Letters. 46:1995;117-124.
12. Thomas, P. T. Bhargava, H. N. House, R. V. Immunomodulatory effects of in vitro exposure to morphine and its metabolites.
13. Bussiere J. L., Adler M. W., Rogers T. J., Eisenstein T. K. Cytokine reversal of morphine-induced suppression of the antibody response. Journal of Pharmacology and Experimental Therapeutics. 264:1993;591-597.
14. Alicea C., Belkowski S., Eisenstein T. K., Adler M. W., Rogers T. J. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the k-opioid against U50,488H. J. Neuroimmunol. 64:1996;83-90.
15. Pacifici R. S., Bacosi A., Caronna A., Di Carlo, Pichini S., Zuccaro P. Immunological consequences of zidovudine treatment in control and morphine or methadone treated mice. Immunopharmac. Immunotoxic. 14:1992;355-381.
16. Jessop J. J., Taplits M. S. Effect of high doses of morphine on Con-A induced lymphokine production in vitro. Immunopharmacol. 22:1991;175-184.
17. Le Vier D. G., McCay J. A., Stern M. L., Harris L. S., Page D., Brown R. D., Musgrove D. L., Butterworth L. F., White K. L., Munson A. E. Immunotoxicological Profile of Morphine Sulfate in B6C3F1 female mice. Fund. Appld. Toxicol. 1994;525-542.
18. Kuprash D. V., Udalova I. A., Turetskaya R. L., Rice N. R., Nedospasov S. A. C. Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene. 11:1995;97-106.
19. Galien R., Evans H. F., Garcia T. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens. Molecular Endocrinology. 10:1996;713-722.
20. Collart M. A., Baeuerle P., Vassali P. Regulation of TNF alpha transcription in Macrophages. Mol. Cell. Biol. 10:1990;1498-1506.
21. Swingler S., Morris A., Easton A. Tumour necrosis factor alpha and interleukin-1 beta induce specific subunits of NFKB to bind the HIV-1 enhancer: characterisation of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells. Biochem. Biophysic. Res. Comm. 203:1994;623-630.
22. Powell J. D., Bednarik D. P., Folks T. M., Jehuda-Cohen T., Villinger F., Sell K. W., Ansari A. A. Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primates. Clinical & Experimental Immunology. 91:1993;473-481.
23. Roy S., Chapin R., Charboneau R., Barke R. A. Sepsis induced release of Interleukin-6 may activate the immediate early gene program through a hypothalamic-hypophyseal mechanism. Surgery. 116:1994;141-149.
24. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1989;Wiley, New York.
25. Sweet M. J., Hume D. A. Endotoxin signal transduction in macrophages. J. Leukocyte. Biol. 60:1996;8-26.
26. Baeuerle P. A., Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NFκB transcription factor. Cell. 53:1988;211-217.